Eligard® 7.5 mg
leuprolide acetate for injectable suspension

330 mg ATRIGEL® Delivery System
This syringe does not contain the active drug

Sterile
For subcutaneous injection

sanofi aventis

LOT:
EXP:

PRINCIPAL DISPLAY PANEL - 7.5 mg Diluent
Syringe B

E-907

Rx Only

NDC 0024-0793-74

Eligard® 7.5 mg

leuprolide acetate for
injectable suspension

Delivers 7.5 mg
leuprolide acetate

Actual content 10.2 mg
lyophilized leuprolide acetate

Dist. by: sanofi-aventis U.S. LLC
Bridgewater, NJ 08807

04100 Rev. 5 2/08

50088124

Lot #

Exp.

PRINCIPAL DISPLAY PANEL - 22.5 mg Carton
E-922

NDC 0024-0222-05

Eligard® 22.5 mg

leuprolide acetate for
injectable suspension

22.5 mg Every 3 months

Sterile

For subcutaneous injection

Must be constituted before use

Store refrigerated 2 to 8°C
(36 to 46°F)

Rx Only

sanofi aventis

PRINCIPAL DISPLAY PANEL - 22.5 mg Syringe
Rx Only
NDC 0024-0223-05
E-922
Syringe A

Eligard® 22.5 mg
leuprolide acetate for injectable suspension

440 mg ATRIGEL® Delivery System
This syringe does not contain the active drug

Sterile
For subcutaneous injection

sanofi aventis

LOT:
EXP:

PRINCIPAL DISPLAY PANEL - 22.5 mg Diluent
Syringe B

E-922

Rx Only

NDC 0024-0222-04

Eligard® 22.5 mg

leuprolide acetate for
injectable suspension

Delivers 22.5 mg
leuprolide acetate

Actual content 28.2 mg
lyophilized leuprolide acetate

Dist. by: sanofi-aventis U.S. LLC
Bridgewater, NJ 08807

04107 Rev. 4 2/08

50088123

Lot #

Exp.

PRINCIPAL DISPLAY PANEL - 30 mg Carton
E-130

NDC 0024-0610-30

Eligard® 30 mg

leuprolide acetate for
injectable suspension

30 mg Every 4 months

Sterile

For subcutaneous injection

Must be constituted before use

Store refrigerated 2 to 8°C
(36 to 46°F)

Rx Only

sanofi aventis

PRINCIPAL DISPLAY PANEL - 30 mg Syringe
Rx Only
NDC 0024-0611-30
E-130
Syringe A

Eligard® 30 mg
leuprolide acetate for injectable suspension

560 mg ATRIGEL® Delivery System
This syringe does not contain the active drug

Sterile
For subcutaneous injection

sanofi aventis

LOT:
EXP:

PRINCIPAL DISPLAY PANEL - 30 mg Diluent
Syringe B

E-130

Rx Only

NDC 0024-0610-29

Eligard® 30 mg

leuprolide acetate for
injectable suspension

Delivers 30 mg
leuprolide acetate

Actual content 35.8 mg
lyophilized leuprolide acetate

Dist. by: sanofi-aventis U.S. LLC
Bridgewater, NJ 08807

04202 Rev. 4 2/08

50088122

Lot #

Exp.

PRINCIPAL DISPLAY PANEL - 45 mg Carton
E-045

NDC 0024-0605-45

Eligard® 45 mg

leuprolide acetate for
injectable suspension

45 mg Every 6 months

Sterile

For subcutaneous injection

Must be constituted before use

Store refrigerated 2 to 8°C
(36 to 46°F)

Rx Only

sanofi aventis

PRINCIPAL DISPLAY PANEL - 45 mg Syringe
Rx ONLY
NDC 0024-0606-45
E-045
Syringe A

Eligard® 45 mg
leuprolide acetate fo